AIMZ Investment Advisors LLC Decreases Position in Haleon plc (NYSE:HLN)

AIMZ Investment Advisors LLC reduced its stake in shares of Haleon plc (NYSE:HLN) by 3.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 70,552 shares of the company’s stock after selling 2,200 shares during the quarter. AIMZ Investment Advisors LLC’s holdings in Haleon were worth $673,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Sierra Ocean LLC acquired a new stake in Haleon in the fourth quarter valued at approximately $26,000. Fortitude Family Office LLC purchased a new position in shares of Haleon in the third quarter valued at $28,000. Versant Capital Management Inc grew its holdings in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after purchasing an additional 3,348 shares in the last quarter. Geneos Wealth Management Inc. purchased a new stake in Haleon during the 4th quarter worth $35,000. Finally, Toronto Dominion Bank lifted its holdings in Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on HLN shares. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Haleon presently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Trading Down 3.9 %

Shares of NYSE HLN opened at $9.81 on Friday. The stock has a market capitalization of $44.39 billion, a P/E ratio of 28.84, a PEG ratio of 2.82 and a beta of 0.28. The stock’s 50 day moving average price is $9.59 and its two-hundred day moving average price is $9.83. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, analysts anticipate that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.